Iterum Therapeutics (ITRM)
(Delayed Data from NSDQ)
$1.01 USD
+0.01 (0.90%)
Updated Oct 4, 2024 03:59 PM ET
After-Market: $1.00 -0.01 (-0.50%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.23 |
EPS Last Quarter | -0.30 |
Last EPS Surprise | 42.31% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.19 |
Next Year | -0.82 |
EPS (TTM) | -2.00 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 0.93M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 0.93M |
Low Estimate | NA | NA | NA | 0.93M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.23 | -0.26 | -1.19 | -0.82 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.23 | -0.26 | -1.19 | -0.82 |
High Estimate | -0.23 | -0.26 | -1.19 | -0.82 |
Low Estimate | -0.23 | -0.26 | -1.19 | -0.82 |
Year ago EPS | -0.30 | -0.94 | -2.96 | -1.19 |
Year over Year Growth Est. | 23.33% | 72.34% | 59.80% | 31.09% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.23 | -0.26 | -1.19 | -0.82 |
7 Days Ago | -0.23 | -0.26 | -1.19 | -0.82 |
30 Days Ago | -0.23 | -0.26 | -1.19 | -0.82 |
60 Days Ago | -0.41 | -0.36 | -1.76 | -1.30 |
90 Days Ago | -0.41 | -0.36 | -1.76 | -1.30 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.23 | -0.26 | -1.19 | -0.82 |
Zacks Consensus Estimate | -0.23 | -0.26 | -1.19 | -0.82 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.30 | -0.46 | -0.94 | -0.30 | NA |
Estimate | -0.52 | -0.57 | -1.02 | -0.91 | NA |
Difference | 0.22 | 0.11 | 0.08 | 0.61 | 0.26 |
Surprise | 42.31% | 19.30% | 7.84% | 67.03% | 34.12% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more